RxDoctor Payments DataLook up a doctor →

Mark Mighell, MD

Orthopaedic Surgery · Temple Terrace, FLNPI 1528065323

Payments from drug & device makers

$4,381,113in general payments, 2019–2025

Across 1,438 payments — averaging $3046.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3.8M
  • Encore Medical, LP$465K
  • Depuy Synthes Products, Inc.$29K
  • Medical Device Business Services, Inc.$15K
  • Zimmer Biomet$6K
  • Pacira Pharmaceuticals Incorporated$6K
  • plus $11K from 29 others
$31,896in research payments, 2019–2025

Across 9 payments — averaging $3543.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$27K
  • Dunamis Medical, LLC$5K

What the payments were for

  • Royalty or licence$2,955,22569%
  • Consulting fees$1,170,28927%
  • Travel & lodging$120,9293%
  • Food & beverage$49,9931%
  • Education$2,7400%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,381,113 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$488,625
Medicare patients
745
Services billed
8,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone94$436
Meloxicam146$377
Ibuprofen16$326
Gabapentin25$283
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$240
Methylprednisolone35$224
Amoxicillin68$184
Clindamycin Hcl24$138
Tramadol Hcl16$78

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Temple Terrace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →